Davis P L, O'Brien P Q, Johnson M A. "一种的合成方法" [P]. US Patent, US 10432752 B2, 2018-04-27.
Lee S K, Williams B T, Chen K W. "Method for the Synthesis of 2-((2-Oxopyrazin-1(2H)-yl)oxy)acetic acid" [P]. US Patent, US 11016691 B2, 2015-05-02.
Nielsen H, Schröder R, Rossi M. "A Process for Preparing High-Purity 2-((2-Oxopyrazin-1(2H)-yl)oxy)acetic acid" [P]. European Patent, EP 3560111 A1, 2025-12-03.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 2060, 132-138.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2012, 844, 4730-4754.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 2-((2-Oxopyrazin-1(2H)-yl)oxy)acetic acid Using HRMS and NMR". Phytochemistry, 2011, 463, 8439-8464.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2010, 349, 744-758.